Here we use cryogenic electron microscopy to determine the structure of TbAQP2 from Trypanosoma brucei, bound to either the substrate glycerol or to the sleeping sickness drugs, pentamidine or ...

An all-oral medicine, Fexinidazole Winthrop, is now available and is being administered for free across Ethiopia, Malawi, ...

This valuable manuscript investigates the localisation of nutrient receptors in bloodstream stage trypanosomes, with implications for both nutrient uptake and immune evasion. Results after direct ...

While elimination of human African trypanosomiasis (HAT)—also known as sleeping sickness—is within reach across the continent, AAT remains a significant burden, with an estimated annual loss ...

Animal Trypanosomiasis remains a significant constraint to animal health and food security in most African countries. The COMBAT project, coordinated by the French Agricultural Research Center for ...

There are two forms of human African trypanosomiasis (HAT): one caused by Trypanosoma brucei gambiense, which is found in 24 countries across West and Central Africa and accounts for more than 92% ...

Guinea, a country in West Africa has successfully eradicated the gambiense form of human African trypanosomiasis (HAT) disease which is also known as sleeping sickness, says WHO. TheHealthSite.com ...

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General Human African trypanosomiasis (HAT), or sleeping sickness, is a vector-borne parasitic disease caused by infected tsetse flies.

Note to the editor Human African trypanosomiasis, also known as sleeping sickness is a vector-borne parasitic disease caused by infection with protozoan parasites belonging to the genus Trypanosoma.

Sleeping sickness, or African trypanosomiasis, is emerging as a global health concern as scientists warn of its potential to spread beyond Africa. Traditionally confined to sub-Saharan Africa, the ...